US Patent Issued to ADS Therapeutics on Dec. 9 for "Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization" (California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,183, issued on Dec. 9, was assigned to ADS Therapeutics LLC (Irvine, Calif.).

"Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization" was invented by Jinsong Ni (Irvine, Calif.) and Rong Yang (Irvine, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions and methods of using nintedanib for treating indications with abnormal neovascularization in the front part of the eye are disclosed."

The patent was filed on Jan. 18, 2024, under Application No. 18/416,302.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...